IPSC moved above its 50-day moving average on November 09, 2026 date and that indicates a change from a downward trend to an upward trend. In 36 of 42 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 86%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where IPSC's RSI Oscillator exited the oversold zone, 25 of 33 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 76%.
The Momentum Indicator moved above the 0 level on November 06, 2026. You may want to consider a long position or call options on IPSC as a result. In 71 of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 80%.
The Moving Average Convergence Divergence (MACD) for IPSC just turned positive on October 15, 2026. Looking at past instances where IPSC's MACD turned positive, the stock continued to rise in 42 of 50 cases over the following month. The odds of a continued upward trend are 84%.
Following a +19.87% 3-day Advance, the price is estimated to grow further. Considering data from situations where IPSC advanced for three days, in 192 of 231 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
The Aroon Indicator entered an Uptrend today. In 141 of 168 cases where IPSC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 84%.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IPSC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
IPSC broke above its upper Bollinger Band on November 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron PE Growth Rating for this company is 19 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. IPSC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 39 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.309) is normal, around the industry mean (3.498). P/E Ratio (-1.806) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (1.824) is also within normal values, averaging (440.869).
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IPSC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
The Moving Average Convergence Divergence (MACD) for PYXS turned positive on October 23, 2026. Looking at past instances where PYXS's MACD turned positive, the stock continued to rise in 43 of 46 cases over the following month. The odds of a continued upward trend are 90%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where PYXS's RSI Indicator exited the oversold zone, 30 of 39 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 77%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 54 of 65 cases where PYXS's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 83%.
Following a +5.59% 3-day Advance, the price is estimated to grow further. Considering data from situations where PYXS advanced for three days, in 214 of 251 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.
The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on PYXS as a result. In 71 of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 88%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PYXS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for PYXS entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 16 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 80 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (12.103) is normal, around the industry mean (3.498). P/E Ratio (-1.186) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (19.120) is also within normal values, averaging (440.869).
The Tickeron Price Growth Rating for this company is 83 (best 1 - 100 worst), indicating slightly worse than average price growth. PYXS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PYXS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
| IPSC | PYXS | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 76% | 2 days ago 77% |
| Stochastic ODDS (%) | 2 days ago 90% | 2 days ago 83% |
| Momentum ODDS (%) | 2 days ago 80% | 2 days ago 88% |
| MACD ODDS (%) | 2 days ago 84% | 2 days ago 90% |
| TrendWeek ODDS (%) | 2 days ago 82% | 2 days ago 88% |
| TrendMonth ODDS (%) | 2 days ago 84% | 2 days ago 88% |
| Advances ODDS (%) | 3 days ago 83% | 3 days ago 85% |
| Declines ODDS (%) | 17 days ago 90% | 9 days ago 90% |
| BollingerBands ODDS (%) | 2 days ago 90% | N/A |
| Aroon ODDS (%) | 2 days ago 84% | 2 days ago 88% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
IPSC’s FA Score shows that 1 FA rating(s) are green while PYXS’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
IPSC’s TA Score shows that 6 TA indicator(s) are bullish while PYXS’s TA Score has 4 bullish TA indicator(s).
IPSC (@Biotechnology) experienced а +10.53% price change this week, while PYXS (@Biotechnology) price change was -0.61% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was +4.90%. For the same industry, the average monthly price growth was -2.72%, and the average quarterly price growth was -13.41%.
IPSC is expected to report earnings on Nov 12, 2026.
PYXS is expected to report earnings on Mar 24, 2027.
Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
A.I.dvisor indicates that over the last year, IPSC has been loosely correlated with GLUE. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if IPSC jumps, then GLUE could also see price increases.
| Ticker / NAME | Correlation To IPSC | 1D Price Change % | ||
|---|---|---|---|---|
| IPSC | 100% | -7.18% | ||
| GLUE - IPSC | 42% Loosely correlated | -0.76% | ||
| ANRO - IPSC | 40% Loosely correlated | +2.91% | ||
| PYXS - IPSC | 39% Loosely correlated | -4.12% | ||
| AKBA - IPSC | 38% Loosely correlated | +1.69% | ||
| AGIO - IPSC | 37% Loosely correlated | +1.21% | ||
More | ||||
A.I.dvisor indicates that over the last year, PYXS has been loosely correlated with ALT. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if PYXS jumps, then ALT could also see price increases.
| Ticker / NAME | Correlation To PYXS | 1D Price Change % | ||
|---|---|---|---|---|
| PYXS | 100% | -4.12% | ||
| ALT - PYXS | 37% Loosely correlated | -8.49% | ||
| BLRX - PYXS | 37% Loosely correlated | -13.53% | ||
| IPSC - PYXS | 35% Loosely correlated | -7.18% | ||
| RZLT - PYXS | 33% Loosely correlated | +4.09% | ||
| FDMT - PYXS | 31% Poorly correlated | -0.16% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| CAOS | 91.45 | 0.15 | +0.16% |
| Alpha Architect Tail Risk ETF (CAOS) | |||
| RCLR | 51.45 | N/A | N/A |
| Reckoner BBB-B Clo Reinvesting ETF | |||
| OCTU | 30.41 | -0.11 | -0.37% |
| AllianzIM U.S. Equity Buffer15 Uncapped Oct ETF (OCTU) | |||
| JCPB | 45.33 | -0.31 | -0.68% |
| JPMorgan Core Plus Bond ETF (JCPB) | |||
| SRET | 20.18 | -0.21 | -1.01% |
| Global X SuperDividend REIT ETF (SRET) | |||